NS

Naman Sharma

Active Director Director DIN 02140419
DIN 02140419 First appointment Apr 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Apr 2008
Shareholding value •••• Premium profile

About Naman Sharma

Data last updated:

Naman Sharma is a Director at Rusoma Laboratories Private Limited (since 2008), Director at Juror Analyticals & Research Private Limited (since 2016) and Director at Rusoma Lifesciences Private Limited (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Paper and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹75.81 Cr; the largest is Rusoma Laboratories Private Limited at ₹75.80 Cr (FY 2024). Earlier, Naman Sharma was a Director at Vedelik Healthcare Private Limited (2019–2021) and Director at Agir Lifesciences Private Limited (2019–2022).

DIN 02140419
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2008
Oldest Company Age 48 yrs
Largest company Rusoma Laboratories Private Limited · ₹75.80 Cr (FY 2024)
Combined revenue ₹75.81 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rusoma Laboratories Private Limited U24230MH1978PTC020467
Director01 Apr 20081978₹75.80 Cr (FY 2024)Active
Director17 May 20162016₹50,030 (FY 2025)Active
Rusoma Lifesciences Private Limited U21003MP2024PTC071858
Director24 Jun 20242024Active
Designated Partner25 Jun 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vedelik Healthcare Private Limited U24110MP2019PTC049908
Director24 Oct 20192019₹16.7 Lakh (FY 2021)Amalgamated
Agir Lifesciences Private Limited U24100MP2019PTC048406
Director22 Apr 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rumoya Healthcare Llp
Rusoma Laboratories Private Limited
Juror Analyticals & Research Private Limited
Rusoma Lifesciences Private Limited
Premium access

Shareholding and investment profile for Naman Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naman Sharma

Naman Sharma currently holds 4 directorships: Rusoma Laboratories Private Limited (Director, since 01 Apr 2008, revenue ₹75.80 Cr (FY 2024)); Juror Analyticals & Research Private Limited (Director, since 17 May 2016, revenue ₹50,030 (FY 2025)); Rusoma Lifesciences Private Limited (Director, since 24 Jun 2024); Rumoya Healthcare Llp (Designated Partner, since 25 Jun 2019).

Naman Sharma was first appointed on 01 Apr 2008 as Director at Rusoma Laboratories Private Limited. The most recent appointment on record is 24 Jun 2024 at Rusoma Lifesciences Private Limited.

The 2 current companies of Naman Sharma that report revenue have a combined latest revenue of ₹75.81 Cr: Rusoma Laboratories Private Limited ₹75.80 Cr (FY 2024); Juror Analyticals & Research Private Limited ₹50,030 (FY 2025).

Naman Sharma held 2 earlier board appointments: Vedelik Healthcare Private Limited (Director, 24 Oct 2019 to 22 Jan 2021); Agir Lifesciences Private Limited (Director, 22 Apr 2019 to 08 Nov 2022).

The current boards of Naman Sharma's companies include Anand Mohan Sharma (Rusoma Laboratories Private Limited), Mahesh Chandra Sharma (Rusoma Laboratories Private Limited), Tapan Sharma (Rusoma Laboratories Private Limited), Devendra Mehta (Rusoma Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available